Cory Lance
Vendite & Marketing presso Courtagen Life Sciences, Inc.
Profilo
Cory Lance is currently the Director-West Region Sales at Courtagen Life Sciences, Inc. He previously worked as the Manager-National Sales at Transgenomic, Inc. and as the Manager-District Sales at IMPAC Medical Systems, Inc. Mr. Lance completed his undergraduate degree at The Ohio State University.
Posizioni attive di Cory Lance
| Società | Posizione | Inizio |
|---|---|---|
Courtagen Life Sciences, Inc.
 Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Vendite & Marketing | - |
Precedenti posizioni note di Cory Lance
| Società | Posizione | Fine |
|---|---|---|
IMPAC Medical Systems, Inc.
 IMPAC Medical Systems, Inc. Packaged SoftwareTechnology Services IMPAC Medical Systems, Inc. develops integrated software for oncology. It provides integrated clinical and administrative management systems for cancer specialists. The company was founded by Joseph K. Jachinowski, James P. Hoey and David A. Auerbach in January 1990 and is headquartered in Sunnyvale, CA. | Vendite & Marketing | - |
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Vendite & Marketing | - |
Formazione di Cory Lance
| The Ohio State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Electronic Technology |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc. Packaged SoftwareTechnology Services IMPAC Medical Systems, Inc. develops integrated software for oncology. It provides integrated clinical and administrative management systems for cancer specialists. The company was founded by Joseph K. Jachinowski, James P. Hoey and David A. Auerbach in January 1990 and is headquartered in Sunnyvale, CA. | Technology Services |
- Borsa valori
- Insiders
- Cory Lance
